EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies

Farzaneh Darbeheshti iD, G Mike Makrigiorgos iD

International Journal of Molecular Sciences · 04.01.2023 · 24 (2) · 923

DOI: 10.3390/ijms24020923 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.01.2023. Verfasst von Farzaneh Darbeheshti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, institutional funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low-level tumor somatic DNA mutations in tissue and liquid biopsies obtained from cancer patients can have profound implications for development of metastasis, prognosis, choice of treatment, follow-up, or early cancer detection. Unless detected, such low-frequency DNA alterations can misinform patient management decisions or become missed opportunities for personalized medicine. Next-generation sequencing technologies and digital-PCR can resolve low-level mutations but require access to specialized instrumentation, time, and resources. Enzymatic-based approaches to detection of low-level mutations provide a simple, straightforward, and affordable alternative to enrich and detect such alterations and is broadly available to low-resource laboratory settings. This review summarizes the traditional uses of enzymatic mutation detection and describes the latest exciting developments, potential, and applications with specific reference to the field of liquid biopsy in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansLiquid BiopsyDNA, NeoplasmMutationPolymerase Chain ReactionHigh-Throughput Nucleotide SequencingBiomarkers, Tumor

Stichwörter der Autor:innen

low-level mutationsmutation detectionnucleotide mismatchespolymerase chain reaction

Substanzen

DNA, NeoplasmBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.

ORCID-Profile: Farzaneh Darbeheshti, G Mike Makrigiorgos

Förderung

  • NCI NIH HHS
  • institutional funds

Zitieren

APA

Darbeheshti, F., & Makrigiorgos, G. M. (2023). Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies. International Journal of Molecular Sciences, 24(2), 923. https://doi.org/10.3390/ijms24020923

Vancouver

Darbeheshti F, Makrigiorgos GM. Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies. International Journal of Molecular Sciences. 2023;24(2):923. doi:10.3390/ijms24020923

BibTeX
@article{Darbeheshti2023,
  author = {Darbeheshti, Farzaneh and Makrigiorgos, G Mike},
  title = {Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {2},
  pages = {923},
  doi = {10.3390/ijms24020923}
}
Kostenlos starten →